Robert Redfield

Executive

US·SEC (Form 4)

Traws Pharma, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 16 Dec 2025 for Traws Pharma, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Robert Redfield: trading record in brief

Robert Redfield discloses dealings in Traws Pharma, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 1 April 2024 and the latest from 12 December 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 16 December 2025: a share grant, in Traws Pharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.